{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:56:58Z","timestamp":1778522218573,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1124\/jpet.301.1.266","type":"journal-article","created":{"date-parts":[[2003,1,10]],"date-time":"2003-01-10T18:34:02Z","timestamp":1042223642000},"page":"266-276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Intravenous Buprenorphine Self-Administration by Detoxified Heroin Abusers"],"prefix":"10.1016","volume":"301","author":[{"given":"Sandra D.","family":"Comer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric D.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian W.","family":"Fischman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1124\/jpet.301.1.266_bib1","first-page":"S6","article-title":"Abuse liability of IV buprenorphine-naloxone, buprenorphine, and hydromorphone in buprenorphine-naloxone maintained volunteers.","volume":"60","author":"Amass","year":"2000","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.301.1.266_bib2","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1177\/106002809703100706","article-title":"Abuse of prescription medicines in southwestern France.","volume":"31","author":"Baumevieille","year":"1997","journal-title":"Ann Pharmacother"},{"key":"10.1124\/jpet.301.1.266_bib3","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1037\/1064-1297.3.4.477","article-title":"Buprenorphine treatment of opioid dependence: a review.","volume":"3","author":"Bickel","year":"1995","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1124\/jpet.301.1.266_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0376-8716(87)90069-X","article-title":"Effects of buprenorphine in heroin addicts.","volume":"20","author":"Blom","year":"1987","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.301.1.266_bib5","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/00008877-199712000-00002","article-title":"Choice between money and intranasal heroin in morphine-maintained humans.","volume":"8","author":"Comer","year":"1997","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.301.1.266_bib6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s002130000623","article-title":"Buprenorphine sublingual tablets: effects on IV heroin self-administration by humans.","volume":"154","author":"Comer","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.301.1.266_bib7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s002130050956","article-title":"Comparison of intranasal and intravenous heroin self-administration by morphine-maintained humans.","volume":"143","author":"Comer","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.301.1.266_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0014-2999(97)01572-0","article-title":"Effect of an alternative reinforcer on i.v. heroin self-administration by humans.","volume":"345","author":"Comer","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.301.1.266_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00008877-199402000-00009","article-title":"Effects of buprenorphine on self-administration of cocaine by humans.","volume":"5","author":"Foltin","year":"1994","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.301.1.266_bib10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1037\/1064-1297.3.3.261","article-title":"Interaction of buprenorphine with cocaine-morphine combinations.","volume":"3","author":"Foltin","year":"1995","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1124\/jpet.301.1.266_bib11","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/clpt.1989.66","article-title":"Sublingual versus subcutaneous buprenorphine in opiate abusers.","volume":"45","author":"Jasinski","year":"1989","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.301.1.266_bib12","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1001\/jama.1992.03480200058024","article-title":"A controlled trial of buprenorphine treatment for opioid dependence.","volume":"267","author":"Johnson","year":"1992","journal-title":"J Am Med Assoc"},{"key":"10.1124\/jpet.301.1.266_bib13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0014-2999(00)00039-X","article-title":"Buprenorphine and methoclocinnamox: agonist and antagonist effects on respiratory function in rhesus monkeys.","volume":"391","author":"Kishioka","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.301.1.266_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/archpsyc.1996.01830050035005","article-title":"A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence.","volume":"53","author":"Ling","year":"1996","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/jpet.301.1.266_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0376-8716(88)90053-1","article-title":"Progressive ratio performance maintained by buprenorphine, heroin and methadone in Macaque monkeys.","volume":"21","author":"Mello","year":"1988","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.301.1.266_bib16","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0006-3223(96)00266-1","article-title":"Buprenorphine and naloxone interactions in methadone maintenance patients.","volume":"41","author":"Mendelson","year":"1997","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.301.1.266_bib17","series-title":"Buprenorphine: Combating Drug Abuse with a Unique Opioid","first-page":"71","article-title":"Reinforcing effects, discriminative stimulus effects, and physical dependence liability of buprenorphine","author":"Negus","year":"1995"},{"key":"10.1124\/jpet.301.1.266_bib18","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1360-0443.1988.tb00536.x","article-title":"Buprenorphine abuse among opiate addicts.","volume":"83","author":"O\u2019Connor","year":"1988","journal-title":"Brit J Addict"},{"key":"10.1124\/jpet.301.1.266_bib19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1037\/1064-1297.7.1.38","article-title":"Buprenorphine dose self-selection: effects of an alternative reinforcer, behavioral economic analysis of demand, and examination of subjective drug effects.","volume":"7","author":"Petry","year":"1999","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1124\/jpet.301.1.266_bib20","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/clpt.1993.72","article-title":"Subjective and physiologic effects of intravenous buprenorphine in humans.","volume":"53","author":"Pickworth","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.301.1.266_bib21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00544557","article-title":"Psychomotor, respiratory and neuroendocrinological effects of buprenorphine and amitriptyline in healthy volunteers.","volume":"33","author":"Saarialho-Kere","year":"1987","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/jpet.301.1.266_bib22","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1360-0443.1989.tb00589.x","article-title":"Buprenorphine and temazepam abuse by drug takers in Glasgow: an increase.","volume":"84","author":"Sakol","year":"1989","journal-title":"Br J Addict"},{"key":"10.1124\/jpet.301.1.266_bib23","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s002130051045","article-title":"Onset, magnitude and duration of opioid blockade produced by buprenorphine and naltrexone in humans.","volume":"145","author":"Schuh","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1124\/jpet.301.1.266_bib24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1600-0447.1992.tb03224.x","article-title":"Cases of buprenorphine abuse in India.","volume":"86","author":"Singh","year":"1992","journal-title":"Acta Psychiatr Scand"},{"key":"10.1124\/jpet.301.1.266_bib25","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s002130000637","article-title":"Effects of buprenorphine\/naloxone in opioid-dependent humans.","volume":"154","author":"Stoller","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1124\/jpet.301.1.266_bib26","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1176\/ajp.151.7.1025","article-title":"Comparison of buprenorphine and methadone in the treatment of opioid dependence.","volume":"151","author":"Strain","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.1124\/jpet.301.1.266_bib27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s002130050199","article-title":"The effects of buprenorphine in buprenorphine-maintained volunteers.","volume":"129","author":"Strain","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.301.1.266_bib28","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0022-3565(25)09651-X","article-title":"Buprenorphine antagonism of \u03bc-opioids in the rhesus monkey tail-withdrawal procedure.","volume":"273","author":"Walker","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.301.1.266_bib29","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/BF02246290","article-title":"Effects of buprenorphine and methadone in methadone-maintained subjects.","volume":"119","author":"Walsh","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.301.1.266_bib30","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0022-3565(25)10510-7","article-title":"Acute administration of buprenorphine in humans: partial agonist and blockade effects.","volume":"274","author":"Walsh","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.301.1.266_bib31","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenorphine: ceiling effects at high doses.","volume":"55","author":"Walsh","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.301.1.266_bib32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0022-3565(25)10977-4","article-title":"Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys.","volume":"261","author":"Winger","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.301.1.266_bib33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0376-8716(00)00166-6","article-title":"The effects of chronic morphine on behavior reinforced by several opioids or by cocaine in rhesus monkeys.","volume":"62","author":"Winger","year":"2001","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.301.1.266_bib34","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0022-3565(25)21772-4","article-title":"Reinforcing and discriminative stimulus properties of mixed agonist-antagonist opioids.","volume":"229","author":"Young","year":"1984","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.301.1.266_bib35","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0022-3565(24)36921-6","article-title":"Comparing the subjective, psychomotor and physiological effects of intravenous buprenorphine and morphine in healthy volunteers.","volume":"282","author":"Zacny","year":"1997","journal-title":"J Pharmacol Exp Ther"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524356022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524356022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.301.1.266","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T23:17:41Z","timestamp":1740007061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524356022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["S0022356524356022"],"URL":"https:\/\/doi.org\/10.1124\/jpet.301.1.266","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2002,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous Buprenorphine Self-Administration by Detoxified Heroin Abusers","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.301.1.266","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2002 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}